SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-24-000015
Filing Date
2024-02-01
Accepted
2024-01-31 21:34:30
Documents
13
Period of Report
2024-01-31

Document Format Files

Seq Description Document Type Size
1 6-K a2024-02x01appendix4c.htm 6-K 20491
2 EX-99.1 exhibit991.htm EX-99.1 33166
3 exhibit991001.jpg GRAPHIC 269480
4 exhibit991002.jpg GRAPHIC 266393
5 exhibit991003.jpg GRAPHIC 281937
6 exhibit991004.jpg GRAPHIC 254769
7 exhibit991005.jpg GRAPHIC 120717
8 exhibit991006.jpg GRAPHIC 126438
9 exhibit991007.jpg GRAPHIC 102680
10 exhibit991008.jpg GRAPHIC 110593
11 exhibit991009.jpg GRAPHIC 212873
12 exhibit991010.jpg GRAPHIC 162996
13 exhibit991011.jpg GRAPHIC 118705
  Complete submission text file 0001345099-24-000015.txt   2848096
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 24584807
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)